We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Prof. Paulus Kirchhof

Prof. Paulus Kirchhof FESC, FRCP (Ed)

Professor of Cardiovascular Medicine, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS Trusts, Birmingham, United Kingdom
Professor Paulus Kirchhof is Deputy Director of the Institute of Cardiovascular Sciences and Professor of Cardiovascular Medicine at the College of Medical and Dental Sciences, University of Birmingham, UK. His appointment includes a position as consultant cardiologist at SWBH NHS and UHB NHS trusts. He has worked on several guidelines of the European Society of Cardiology including as chair of the 2016 ESC guidelines for atrial fibrillation. Professor Kirchhof chairs the board of the Atrial Fibrillation NETwork (AFNET), is a member of the Board of the European Heart Rhythm Association, and sits on the board of the European Society of Cardiology.
Professor Kirchhof researches mechanisms and management of cardiovascular diseases with a special interest in atrial fibrillation and cardiomyopathies. He has published > 250 peer reviewed papers. He leads a translational research group in Birmingham that works across the university and its major NHS partners (UHB and SWBH). He also has a long-standing experience in the planning and conduct of international multi-centre investigator-initiated trials, including work as Chief Investigator, steering committee member, and data monitoring committee member. His research is funded by British Heart Foundation, Leducq Foundation, European Union, and others. Working closely with international collaborators, his research group uses genetically modified models, controlled clinical trials and trial data bases, imaging data and biosamples from trial participants, and observational cohorts in a translational team approach to science and health care. He uses these resources to improve the management of patients with atrial fibrillation and cardiomyopathies, to develop personalized therapies for AF patients, and to improve cardiovascular health in general.
Professor Kirchhof is an enthusiastic teacher, regular supervisor for MD and PhD students (over 20 completed MD and PhD degrees), and a sought-after speaker. He helps to coordinate cardiovascular curricula in Medicine and post-graduate courses in cardiovascular medicine, contributes to major textbooks in the field, and serves as educational supervisor for medicine and cardiology trainees in Birmingham. Professor Kirchhof runs a large atrial fibrillation service based at SWBH NHS trust and coordinates the interdisciplinary Inherited Cardiac Conditions Clinic at UHB NHS trust.

Disclosures

PK has received research support from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Centre for Heart Research, from several drug and device companies active in atrial fibrillation, and has received honoraria from several such companies. In addition, Dr. Kirchhof is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783).